Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid

Completed

Phase N/A Results

Summary of Purpose

To assess the effectiveness of epsilon-aminocaproic acid (EACA) in reducing immediate recurrence in patients with spontaneous subarachnoid hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 March 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, controlled clinical trial of 165 patients.

Contacts

Not available